[HTML][HTML] Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer

SI Bril, N Chargi, AW Wendrich, I Wegner, GH Bol… - Oral Oncology, 2021 - Elsevier
Background Low skeletal muscle mass (SMM) is associated with adverse outcomes. SMM is
often assessed at the third lumbar vertebra (L3) on abdominal imaging. Abdominal imaging …

Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis

M Findlay, K White, N Stapleton, J Bauer - Clinical Nutrition, 2021 - Elsevier
Introduction Computed tomography (CT)-defined sarcopenia is a demonstrated poor
prognostic factor for survival in patients with cancer, however, its impact in patients with …

The association of pretreatment low skeletal muscle mass with chemotherapy dose‐limiting toxicity in patients with head and neck cancer undergoing primary …

SI Bril, A Al‐Mamgani, N Chargi, P Remeijer… - Head & …, 2022 - Wiley Online Library
Background Low skeletal muscle mass (SMM) is an adverse prognostic factor for
chemotherapy dose‐limiting toxicity (CDLT). In patients with locally advanced head and …

[HTML][HTML] Cancer cachexia: new insights and future directions

CR Mariean, OM Tiucă, A Mariean, OS Cotoi - Cancers, 2023 - mdpi.com
Simple Summary Cancer is a major burden of disease worldwide, with cancer cachexia
being a poor prognosis factor which leads to a decreased quality of life and overall survival …

The prevalence and the impact of sarcopenia in digestive cancers. A systematic review

C Haiducu, A Buzea, LE Mirea, GA Dan - Romanian Journal of Internal …, 2021 - sciendo.com
The prevalence and the impact of sarcopenia in digestive cancers. A systematic review Page
1 ROM. J. INTERN. MED., 2021, 59, 4, 328–344 The prevalence and the impact of sarcopenia …

[HTML][HTML] The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study)

B Raynard, F Pigneur, M Di Palma, E Deluche… - Supportive Care in …, 2022 - Springer
Background Cachexia, characterized by involuntary muscle mass loss, negatively impacts
survival outcomes, treatment tolerability, and functionality in cancer patients. However, there …

Low skeletal muscle mass as a risk factor for postoperative delirium in elderly patients undergoing colorectal cancer surgery

CA Mosk, JLA Van Vugt, H De Jonge… - … interventions in aging, 2018 - Taylor & Francis
Background Both low skeletal muscle mass (LSMM) and delirium are frequently seen in
elderly patients. This study aimed to investigate the association between preoperative …

[HTML][HTML] Different nutritional screening tools and recommended screening algorithm for pediatric oncology patients

N Gallo, K Horvath, K Czuppon, E Tomsits… - Clinical nutrition, 2021 - Elsevier
Background & aims Cancer is one of the leading causes of death for children; however,
appropriate nutritional status can positively affect disease progression and outcome. The …

Body composition predicts clinical outcome in patients with intestinal failure on long-term home parenteral nutrition

M Køhler, SS Olesen, HH Rasmussen - Clinical nutrition ESPEN, 2018 - Elsevier
Background & aims Patients with chronic intestinal failure (CIF) are at risk of altered body
composition and impaired muscle function, which may negatively affect clinical outcome …

Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with …

N Chargi, O Breik, T Forouzanfar, T Martin… - Head & …, 2022 - Wiley Online Library
Background Skeletal muscle mass (SMM) and chronic inflammation are associated with
postoperative complications and survival. Methods Patients with head and neck cancer …